Literature DB >> 24469390

Haemostatic trends in HIV-infected individuals in Yaoundé, Cameroon: a pilot study.

Larissa Tene1, Claude T Tagny, Annick Mintya-Ndoumba, Victor N Fossi, Dora Mbanya.   

Abstract

Bleeding disorders are haematological manifestations that are frequently observed during HIV infection. This study intends to describe the haemostatic trends in HIV-infected patients in Cameroon. This cross-sectional descriptive study was carried out at the haematology unit of the Yaoundé University Teaching Hospital from March to June 2012. It included consenting HIV-positive patients, aged 18 years and above, naive to antiretroviral treatment or not. The coagulation profile was measured with Stago reagents (Stago Diagnostics, Asnières sur Seine, France) using a chronometric technique on a semi-automate (Stago Diagnostics). Platelets count was estimated on a human count automate (Human Diagnostics, Wiesbaden, Germany) by flow cytometry. A total of 139 HIV-infected patients were included in this study, out of which 106 were females (76.3%) against 33 (23.7%) males, giving a sex ratio of 0.3 (M/F). Mean age was 38.85 years (range 22-73 years) and median CD4 count was 353 cells/μl (Interquartile range 200-500 cells/μl). Hyperfibrinogenaemia was the most frequent bleeding disorder in the studied population [40 of 139 (28.78%)], followed by low prothrombin time (PT) [22 of 139 (15.83%)], thrombocytopenia [19 of 139 (13.67%)], hypofibrinogenaemia [18 of 139 (12.95)], prolonged activated partial thromboplastin time (7.91) and by thrombocytosis which was less frequent [6 of 139 (4.32%)]. Out of the six haemostatic disorders, only low PT was significantly associated with CD4 count (P = 0.02). This study showed that bleeding disorders are very frequent in the HIV-infected patients studied. Low PT was significantly associated with CD4 count, hence it may be recommended to systematic screen for bleeding disorders in severe immune-depressed (CD4 ≤ 200 cells/μl) HIV-infected patients.

Entities:  

Mesh:

Year:  2014        PMID: 24469390      PMCID: PMC5061029          DOI: 10.1097/MBC.0000000000000066

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  10 in total

Review 1.  Cardiovascular implications from untreated human immunodeficiency virus infection.

Authors:  Jason V Baker; Jens D Lundgren
Journal:  Eur Heart J       Date:  2011-01-12       Impact factor: 29.983

2.  Correlation of CD4 count with platelet count, prothrombin time and activated partial thromboplastin time among HIV patients in Benin City, Nigeria.

Authors:  R Omoregie; S I Osakue; V Ihemeje; E U Omokaro; H O Ogeferet
Journal:  West Indian Med J       Date:  2009-11       Impact factor: 0.171

3.  [Aetiologic factors and clinical features associated with thrombocytopenia in Cameroonese adults: the importance of Plasmodium falciparum malaria].

Authors:  Dora Mbanya; Jean-Baptiste Tapko; François Azowe; Lazare Kaptue
Journal:  Sante       Date:  2002 Jul-Sep

4.  Haemorheologic and fibrinolytic activity in Nigerian HIV infected patients.

Authors:  Richard Omoregie; Judith E Adeghe; Helen O Ogefere; Evelyn U Omokaro; Chinedu C Ekeh
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

Review 5.  Risk factors for venous thromboembolism in patients with human immunodeficiency virus infection.

Authors:  Katie L Kiser; Melissa E Badowski
Journal:  Pharmacotherapy       Date:  2010-12       Impact factor: 4.705

Review 6.  [HIV-related thrombocytopenias].

Authors:  P M Mannucci; A Gringeri
Journal:  Ann Ital Med Int       Date:  2000 Jan-Mar

7.  [Circulating anticoagulants in immunodeficiency virus infection. Results of a prospective study of 157 seropositive patients].

Authors:  B Taillan; C Roul; J G Fuzibet; H Vinti; A Pesce; J Bayle; J P Cassuto; P Dujardin
Journal:  Ann Med Interne (Paris)       Date:  1989

Review 8.  Fibrinogen: a new major risk factor for cardiovascular disease. A review of the literature.

Authors:  G de la Serna
Journal:  J Fam Pract       Date:  1994-11       Impact factor: 0.493

Review 9.  [Hemostasis and human immunodeficiency virus (HIV) infection].

Authors:  P Toulon
Journal:  Ann Biol Clin (Paris)       Date:  1998 Mar-Apr       Impact factor: 0.459

10.  Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia.

Authors:  Se Youn Choi; Inho Kim; Nam Joong Kim; Seung-Ah Lee; Youn-Ak Choi; Ji-Yeon Bae; Ji Hyun Kwon; Pyoeng Gyun Choe; Wan Beom Park; Sung-Soo Yoon; Seonyang Park; Byoung Kook Kim; Myoung-Don Oh
Journal:  Korean J Hematol       Date:  2011-12-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.